ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02165202
Brief Title: Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (TMC278LA)

First Submitted : May 21, 2014
First Submitted that Met QC Criteria : June 13, 2014
First Posted : June 17, 2014 (Estimate)

Results First Submitted : July 2, 2018
Results First Submitted that Met QC Criteria : July 2, 2018
Results First Posted : July 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : July 27, 2018
Last Update Posted : August 27, 2018